Altus sells MGCD to CAIRE; plus, Thoma Bravo, Churchill and Nordic share 2023 outlooks

Altus Capital exits MGC Diagnostics.

3 January 2023•6 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.